Literature DB >> 20462973

Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.

Hui Li1, Ramon F Thali, Christy Smolak, Fan Gong, Rodrigo Alzamora, Theo Wallimann, Roland Scholz, Núria M Pastor-Soler, Dietbert Neumann, Kenneth R Hallows.   

Abstract

The metabolic sensor AMP-activated protein kinase (AMPK) regulates several transport proteins, potentially coupling transport activity to cellular stress and energy levels. The creatine transporter (CRT; SLC6A8) mediates creatine uptake into several cell types, including kidney epithelial cells, where it has been proposed that CRT is important for reclamation of filtered creatine, a process critical for total body creatine homeostasis. Creatine and phosphocreatine provide an intracellular, high-energy phosphate-buffering system essential for maintaining ATP supply in tissues with high energy demands. To test our hypothesis that CRT is regulated by AMPK in the kidney, we examined CRT and AMPK distribution in the kidney and the regulation of CRT by AMPK in cells. By immunofluorescence staining, we detected CRT at the apical pole in a polarized mouse S3 proximal tubule cell line and in native rat kidney proximal tubules, a distribution overlapping with AMPK. Two-electrode voltage-clamp (TEV) measurements of Na(+)-dependent creatine uptake into CRT-expressing Xenopus laevis oocytes demonstrated that AMPK inhibited CRT via a reduction in its Michaelis-Menten V(max) parameter. [(14)C]creatine uptake and apical surface biotinylation measurements in polarized S3 cells demonstrated parallel reductions in creatine influx and CRT apical membrane expression after AMPK activation with the AMP-mimetic compound 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. In oocyte TEV experiments, rapamycin and the AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-monophosphate (ZMP) inhibited CRT currents, but there was no additive inhibition of CRT by ZMP, suggesting that AMPK may inhibit CRT indirectly via the mammalian target of rapamycin pathway. We conclude that AMPK inhibits apical membrane CRT expression in kidney proximal tubule cells, which could be important in reducing cellular energy expenditure and unnecessary creatine reabsorption under conditions of local and whole body metabolic stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462973      PMCID: PMC2904179          DOI: 10.1152/ajprenal.00162.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  48 in total

Review 1.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

Review 2.  Creatine: biosynthesis, regulation, and function.

Authors:  J B Walker
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

Review 3.  The creatine-creatine phosphate energy shuttle.

Authors:  S P Bessman; C L Carpenter
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells.

Authors:  Kenneth R Hallows; Jill E McCane; Bruce E Kemp; Lee A Witters; J Kevin Foskett
Journal:  J Biol Chem       Date:  2002-11-08       Impact factor: 5.157

Review 5.  The AMP-activated protein kinase pathway--new players upstream and downstream.

Authors:  D Grahame Hardie
Journal:  J Cell Sci       Date:  2004-11-01       Impact factor: 5.285

6.  Creatine transport in brush-border membrane vesicles isolated from rat kidney cortex.

Authors:  Marta García-Delgado; María J Peral; Mercedes Cano; María L Calonge; Anunciación A Ilundáin
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

7.  Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport.

Authors:  Hubert C Chen; Gautam Bandyopadhyay; Mini P Sajan; Yoshinori Kanoh; Mary Standaert; Robert V Farese; Robert V Farese
Journal:  J Biol Chem       Date:  2002-04-26       Impact factor: 5.157

8.  The LKB1 tumor suppressor negatively regulates mTOR signaling.

Authors:  Reuben J Shaw; Nabeel Bardeesy; Brendan D Manning; Lyle Lopez; Monica Kosmatka; Ronald A DePinho; Lewis C Cantley
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

Review 9.  A molecular approach to the concerted action of kinases involved in energy homoeostasis.

Authors:  D Neumann; U Schlattner; T Wallimann
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

10.  Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells.

Authors:  Kenneth R Hallows; Gary P Kobinger; James M Wilson; Lee A Witters; J Kevin Foskett
Journal:  Am J Physiol Cell Physiol       Date:  2003-01-02       Impact factor: 4.249

View more
  26 in total

1.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

2.  Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment.

Authors:  O O Faluyi; S P Masinghe; R L Hayward; S Clive
Journal:  Med Oncol       Date:  2011-02-01       Impact factor: 3.064

Review 3.  The creatine kinase system and pleiotropic effects of creatine.

Authors:  Theo Wallimann; Malgorzata Tokarska-Schlattner; Uwe Schlattner
Journal:  Amino Acids       Date:  2011-03-30       Impact factor: 3.520

4.  AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells.

Authors:  Rodrigo Alzamora; Fan Gong; Christine Rondanino; Jeffrey K Lee; Christy Smolak; Núria M Pastor-Soler; Kenneth R Hallows
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

5.  Mutation in the Monocarboxylate Transporter 12 Gene Affects Guanidinoacetate Excretion but Does Not Cause Glucosuria.

Authors:  Nasser Dhayat; Alexandre Simonin; Manuel Anderegg; Ganesh Pathare; Benjamin P Lüscher; Christine Deisl; Giuseppe Albano; David Mordasini; Matthias A Hediger; Daniel V Surbek; Bruno Vogt; Jörn Oliver Sass; Barbara Kloeckener-Gruissem; Daniel G Fuster
Journal:  J Am Soc Nephrol       Date:  2015-09-16       Impact factor: 10.121

Review 6.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

7.  Activation of the metabolic sensor AMP-activated protein kinase inhibits aquaporin-2 function in kidney principal cells.

Authors:  Mohammad M Al-Bataineh; Hui Li; Kazuhiro Ohmi; Fan Gong; Allison L Marciszyn; Sajid Naveed; Xiaoqing Zhu; Dietbert Neumann; Qi Wu; Lei Cheng; Robert A Fenton; Núria M Pastor-Soler; Kenneth R Hallows
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-17

8.  Regulation of proximal tubule vacuolar H(+)-ATPase by PKA and AMP-activated protein kinase.

Authors:  Mohammad M Al-bataineh; Fan Gong; Allison L Marciszyn; Michael M Myerburg; Núria M Pastor-Soler
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-19

Review 9.  Regulation of ion channels and transporters by AMP-activated kinase (AMPK).

Authors:  Florian Lang; Michael Föller
Journal:  Channels (Austin)       Date:  2013-12-23       Impact factor: 2.581

10.  The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter.

Authors:  Jeannette Abplanalp; Endre Laczko; Nancy J Philp; John Neidhardt; Jurian Zuercher; Philipp Braun; Daniel F Schorderet; Francis L Munier; François Verrey; Wolfgang Berger; Simone M R Camargo; Barbara Kloeckener-Gruissem
Journal:  Hum Mol Genet       Date:  2013-04-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.